Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

MURAT SARI

Profesör

Marmara Üniversitesi Tıp Fakültesi Dahili Tıp Bilimleri Bölümü

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Articles 23 YÖKSİS 23 · OpenAlex 0 Total citations 255 h-index 9 · OpenAlex OpenAlex coverage %74 matched 17 / 23 Q1 articles 4 Scopus · WoS Q1 1 Best field rank #18,929 / 39,749 Main field · top 47.6% Co-authors 78 12 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 17 + YÖKSİS · co-author record: 20
h-index 9 Percentile in Türkiye: 72 #533 of 2,222 at their university by h-index
i10-index
9
Total citations
255
Top 30% in Türkiye
Per article
6.9
FWCI
1.04
1.00 = world average
World top 1%
0
World top 10%
3

Most cited articles

  1. Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer? 2019 36 citations
  2. The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer 2019 31 citations
  3. Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis 2013 23 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 20 articles (106 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Citing publications Crossref 52 publications citing 20 DOI-bearing articles · 3 Türkiye-affiliated
  • 2019 4
  • 2020 21
  • 2021 19
  • 2022 7
  • 2025 1
  1. DOI 10.3892/ol.2025.15357 2025
  2. Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG) TR Sanjay Popat et al. · The Oncologist · 2022
  3. DOI 10.1007/s12094-022-02783-1 2022
  4. DOI 10.1016/j.semcancer.2022.02.007 2022
  5. DOI 10.3904/kjim.2021.438 2022
  6. DOI 10.1016/j.prp.2021.153721 2022
  7. DOI 10.1155/2022/4220786 2022
  8. DOI 10.1016/j.actatropica.2021.106290 2022
  9. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? TR Murat Ayhan et al. · Current Problems in Cancer · 2021
  10. DOI 10.1186/s12885-021-07977-4 2021
  11. DOI 10.1002/ame2.12181 2021
  12. DOI 10.1038/s41598-020-80680-9 2021
  13. DOI 10.3390/biomedicines9111512 2021
  14. DOI 10.1007/s10147-021-01920-0 2021
  15. DOI 10.1016/j.bbrc.2021.06.048 2021
  16. DOI 10.1038/s41416-021-01501-y 2021
  17. DOI 10.1007/s40278-021-88029-3 2021
  18. DOI 10.1038/s41598-021-91851-7 2021
  19. DOI 10.1111/all.14555 2021
  20. DOI 10.2217/fon-2021-0202 2021
  21. DOI 10.4103/jcrt.jcrt_195_20 2021
  22. DOI 10.4103/ijpvm.ijpvm_222_18 2021
  23. DOI 10.1007/s00404-021-05997-w 2021
  24. DOI 10.29413/abs.2021-6.2.11 2021
  25. DOI 10.1016/j.jtho.2020.12.002 2021
  26. DOI 10.37882/2223-2966.2021.01.09 2021
  27. DOI 10.21294/1814-4861-2021-20-3-76-81 2021
  28. Brain metastasis from ovarian carcinoma: Analysis of eight cases from a single radiotherapy center TR Zumrut Bahat et al. · Taiwanese Journal of Obstetrics and Gynecology · 2020
  29. DOI 10.1007/s11523-020-00756-4 2020
  30. DOI 10.3389/fphar.2020.590991 2020

Showing the 30 most recent.

Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Field ranking

Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.

YÖKSİS ?

Works 23

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 6 articles
OpenAlex citation percentile
Top 1%0
Top 10%0
Avg · n 16 %57.4
Other counts

Scopus (SJR)

  • YÖKSİS rows 18

WoS (JCR)

  • YÖKSİS rows 17

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

23articles

Journals with publications

17 journals

Narrow down

Scopus (SJR)
Q14 Q20 Q310 Q44
WoS (JCR)
Q11 Q23 Q33 Q410
TR Index
6articles

Article list

  1. 2020 Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial Balkan Medical Journal DOI 10.4274/balkanmedj.galenos.2020.2019.11.143 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 53.2%
  2. 2020 Rare mutations of epidermal growth factor receptor in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma and the response to erlotinib therapy Journal of Cancer Research and Therapeutics DOI 10.4103/jcrt.JCRT_757_19 YÖKSİS SJR Q3 JCR Q4 OpenAlex 81.8%
  3. 2020 Rapid drug desensitization for platinum‐based chemotherapy drugs significantly increases peripheral blood IL‐10 levels Allergy DOI 10.1111/all.14311 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.3%
  4. 2020 Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life Indian Journal of Cancer DOI 10.4103/ijc.IJC_458_18 YÖKSİS SJR Q3 JCR Q4 OpenAlex 45.1%
  5. 2020 Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option Journal of Cancer Research and Therapeutics DOI 10.4103/jcrt.JCRT_169_19 YÖKSİS SJR Q3 JCR Q4 OpenAlex 0.4%
  6. 2020 Current Trends in the Incidence of Non-small Cell LungCancer in Turkey: Lung Cancer Aging Eurasian Journal of Medical Investigation DOI 10.14744/ejmi.2020.46278 YÖKSİS TR Index OpenAlex 48.9%
  7. 2020 Clinical and Pathological Features of Ewing Sacoma FamilyTumors in Uro-oncology: A Single-Institute Experience Eurasian Journal of Medical Investigation DOI 10.14744/ejmi.2020.34964 YÖKSİS TR Index OpenAlex 44.1%
  8. 2019 The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer Biomolecules DOI 10.3390/biom9090464 YÖKSİS SJR Q1 JCR Q2 OpenAlex 88.5%
  9. 2019 Clinical Significance of Serum Membrane-Bound Mucin-2 Levels in Breast Cancer Biomolecules DOI 10.3390/biom9020040 YÖKSİS SJR Q1 JCR Q2 OpenAlex 58.8%
  10. 2019 ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE Acta Medica Mediterranea DOI 10.19193/0393-6384_2019_1_12 YÖKSİS SJR Q4 JCR Q4
  11. 2019 Myelodysplastic Syndrome After Olaparib Treatment in Heavily Pretreated Ovarian Carcinoma American Journal of Therapeutics DOI 10.1097/MJT.0000000000000838 YÖKSİS SJR Q3 JCR Q3 OpenAlex 61.7%
  12. 2019 Everolimus-Induced Severe Hypertriglyceridemia and Acute Pancreatitis in a Patient With Tuberous Sclerosis American Journal of Therapeutics DOI 10.1097/MJT.0000000000000821 YÖKSİS SJR Q3 JCR Q3 OpenAlex 65.6%
  13. 2019 IGF-1 AND IGFBP-3 IN COLORECTAL CANCER, AN OBSERVATIONAL CASE-CONTROL STUDY Acta Medica Mediterranea DOI 10.19193/0393-6384_2019_1_1 YÖKSİS SJR Q4 JCR Q4
  14. 2019 Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer? Cancer Chemotherapy and Pharmacology DOI 10.1007/s00280-018-3713-6 YÖKSİS SJR Q1 JCR Q2 OpenAlex 68.0%
  15. 2019 Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis Oncology Research and Treatment DOI https://www.karger.com/Article/FullText/494334 YÖKSİS SJR Q3 JCR Q4 OpenAlex 86.0%
  16. 2019 Adjuvant Chemotherapy After Cystectomy for Muscle Invasive Bladder Cancer Türkiye Klinikleri Üroloji - Özel Konular YÖKSİS
  17. 2018 Prolonged Disease Control with Nivolumab in Metastatic Lung Adenocarcinoma During Immunotherapy Era Journal of the College of Physicians and Surgeons Pakistan DOI 10.29271/jcpsp.2018.11.891 YÖKSİS SJR Q3 JCR Q4 OpenAlex 47.8%
  18. 2018 CLINICAL SIGNIFICANCE OF SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AND INSULIN- LIKE GROWTH BINDING PROTEIN-3 (IGFBP-3) IN PATIENTS WITH GASTRIC CANCER Acta Medica Mediterranea DOI 10.19193/0393-6384_2018_6_320 YÖKSİS SJR Q3 JCR Q4
  19. 2018 A One-center Study of Sixteen Patients with Pregnancy-associated Breast Cancer: Clinicopathological Characteristics and Survival ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ DOI 10.21673/anadoluklin.446910 YÖKSİS TR Index OpenAlex 16.1%
  20. 2017 The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma Turkish Journal of Hematology DOI 10.4274/tjh.2016.0161 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 73.0%

Projects 9 See all (9) →

  1. 2017 LOKAL İLERLEMİŞ VEYA METASTATİK RENAL HÜCRELİ KARSİNOM (mRCC) İÇİN BİRİNCİ BASAMAK TEDAVİ OLARAK STANDART BAKIMA (SUNİTİNİB VEYA PAZOPANİB) KIYASLA PEMBROLİZUMAB (MK-3475) ARTI EPACADOSTATIN ETKİLİLİĞİ VE GÜVENLİLİĞİNİN DEĞERLENDİRİLDİĞİ RANDOMİZE, AÇIK ETİKETLİ, FAZ 3 ÇALIŞMA (KEYNOTE-679-ECHO-302) 0 Diğer (Uluslararası) · Tamamlandı 2017-12-01 – 2018-06-19
  2. 2017 TEKRARLAYAN VEYA METASTATİK SKUAMÖZ HÜCRELİ BAŞ BOYUN KARSİNOMUNDA BİRİNCİ BASAMAK TEDAVİ OLARAK PEMBROLİZUMAB ARTI EPACADOSTATIN, PEMBROLİZUMAB MONOTERAPİSİNİN VE EXTREME REJİMİNİN ETKİLİLİĞİNİ VE GÜVENLİLİĞİNİ DEĞERLENDİREN FAZ 3, RANDOMİZE, AÇIK ETİKETLİ KLİNİK ÇALIŞMA (KEYNOTE 669- ECHO-304) 0 Diğer (Uluslararası) · Tamamlandı 2017-12-08 – 2019-09-20
  3. 2017 BAŞ VE BOYUNDA LOKAL İLERİ EVRE SKUAMÖZ HÜCRELİ KARSİNOMU OLAN HASTALARDA TEK BAŞINA KEMORADYASYONA KIYASLA KEMORADYASYONA EŞ ZAMANLI VE İDAME TEDAVİSİ OLARAK UYGULANAN PEMBROLİZUMABI KARŞILAŞTIRAN BİR RANDOMİZE FAZ 3 ÇALIŞMA (KEYNOTE -412) Diğer (Uluslararası) · Tamamlandı 2017-05-08 – 2025-01-07
  4. 2017 DAHA ÖNCE TEDAVİ EDİLMEMİŞ EPİTELYAL OVER KANSERİ HASTALARINDA AVELUMAB’xxIN (MSB0010718C) KEMOTERAPİ İLE BİRLİKTE VE/VEYA KEMOTERAPİ SONRASINDA ETKİLİLİĞİNİ VE GÜVENLİLİĞİNİ DEĞERLENDİREN RANDOMİZE, AÇIK ETİKETLİ, ÇOK MERKEZLİ BİR FAZ 3 ÇALIŞMA 0 Diğer (Uluslararası) · Tamamlandı 2017-05-18 – 2019-10-09
  5. 2016 DAHA ÖNCE PLATİN BAZLI KEMOTERAPİ VE KRİZOTİNİB TEDAVİSİ UYGULANAN ANAPLASTİK LENFOMA KİNAZ POZİTİF İLERİ EVRE KÜÇÜK HÜCRE DIŞI AKCİĞER KANSERLİ HASTALARDA ALEKTİNİB İLE PEMETREKSET VEYA DOSETAKSELİN KARŞILAŞTIRILDIĞI RANDOMİZE, ÇOK MERKEZLİ, FAZ III, AÇIK ETİKETLİ ÇALIŞMA 0 Diğer (Uluslararası) · Tamamlandı 2016-01-29 – 2018-11-22

Books 3

  1. 2020 Onkoloji Hemşireliği Genişletilmiş ve Güncellenmiş 2. Baskı Nobel Tıp Kitabevleri ISBN 978-605-335-505-2 Kitap Bölümü · Bilimsel Kitap
  2. 2017 Onkoloji Cep Kitabı Özet Bilgiler ve Güncel Notlar EMA Tıp Kitabevi ISBN 9786056600388 Kitap Bölümü · Kitap Tercümesi
  3. 2015 Bates Fizik Muayene ve Anamnez Alma Klavuzu Nobel Tıp Kitabevleri ISBN 978-605-335-143-6 Kitap Bölümü · Kitap Tercümesi

Proceedings 32 See all (32) →

  1. 2017 SERVİKS KANSERİNDE NADİR RASTLANA N METASTAZ BÖLGESİ: İSKİOREKTAL FOSSA 22. ULUSAL KANSER KONGRESİ
  2. 2019 Türkiye’de Yaşa Özgü Akciğer Kanseri İnsidans Oranları:Yaşlılarda Akciğer Kanseri Artmaktadır Ulusal Akciğer Sağlığı Kongresi 2019
  3. 2019 DIYABETIK METASTATIK KASTRASYON DIRENÇLIPROSTAT KANSER HASTALARINDA BIRINCI BASAMAKTEDAVISI: PRODMER ÇALIŞMASI 23. ULUSAL KANSER KONGRESİ
  4. 2019 EKTOPİK ADRENOKORTİKOTROPİN SENDROMU ZEMİNİNDEYAŞAMI TEHDİT EDEN HİPOKALEMİ: TEDAVİ SEÇENEKLERİ 21. Ulusal İç Hastalıkları Kongresi
  5. 2019 ES-004 NAZOFARENKS KANSERINDE INDÜKSIYONKEMOTERAPI VE EŞZAMANLI KEMORADYOTERAPI 23. ULUSAL KANSER KONGRESİ

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
78
With an akaturk profile
40
Turkish institutions
12
Co-authored works
%96

Academic co-authors 40

  1. PINAR MUALLA SAİP Profesör · İstanbul Üniversitesi 6
  2. SÜLEYMAN BADEMLER Profesör · İstanbul Üniversitesi 6
  3. SENEM KARABULUT Profesör · İstanbul Üniversitesi 4
  4. CEREN TİLGEN YASASEVER Araştırma Görevlisi · İstanbul Üniversitesi 2
  5. MELTEM EKENEL Profesör · İstanbul Üniversitesi 2
  6. MERT BAŞARAN Profesör · İstanbul Üniversitesi 2
  7. MURAT SERİLMEZ Doktor Öğretim Üyesi · İstanbul Üniversitesi 2
  8. NAZİYE AK Doçent · İstanbul Üniversitesi 2
  9. ABDULLAH SAKİN Profesör · İstanbul Medipol Üniversitesi 1
  10. ASLI AKKOR Profesör · İstanbul Üniversitesi 1
Show all (40)
  1. BAHAÜDDİN ÇOLAKOĞLU Profesör · İstanbul Yeni Yüzyıl Üniversitesi 1
  2. BAŞAK OYAN ULUÇ Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi 1
  3. BÜLENT ERDOĞAN Profesör · Trakya Üniversitesi 1
  4. BÜLENT SAKA Profesör · İstanbul Üniversitesi 1
  5. DİDEM TAŞTEKİN Profesör · İstanbul Üniversitesi 1
  6. ELİF BİLGİN DOĞRU Araştırma Görevlisi · İstanbul Üniversitesi 1
  7. GÜL BAŞARAN Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi 1
  8. GÜLİSTAN BAHAT-ÖZTÜRK Profesör · İstanbul Üniversitesi 1
  9. GÜNNUR DENİZ Profesör · İstanbul Üniversitesi 1
  10. HACER DEMİR Doçent · Afyonkarahisar Sağlık Bilimleri Üniversitesi 1
  11. HAMDULLAH SÖZEN Profesör · İstanbul Üniversitesi 1
  12. KAMURAN İBİŞ Profesör · İstanbul Üniversitesi 1
  13. MEHMET AKİF KARAN Profesör · İstanbul Üniversitesi 1
  14. MESUDE YASEMİN ÖZLÜK Profesör · İstanbul Üniversitesi 1
  15. MUHAMMET BEKİR HACIOĞLU Profesör · Trakya Üniversitesi 1
  16. MURAT ARAZ Profesör · Necmettin Erbakan Üniversitesi 1
  17. NAZIM CAN DEMİRCAN Doçent · Marmara Üniversitesi same university 1
  18. NURİ KARADURMUŞ Profesör · Sağlık Bilimleri Üniversitesi 1
  19. OSMAN KÖSTEK Doçent · Marmara Üniversitesi same university 1
  20. SAADETTİN KILIÇKAP Profesör · İstinye Üniversitesi 1
  21. SAMET TOPUZ Profesör · İstanbul Üniversitesi 1
  22. SEBİLE NİLGÜN ERTEN Profesör · İstanbul Üniversitesi 1
  23. SERNAZ TOPALOĞLU Profesör · Trakya Üniversitesi 1
  24. SİBEL AKIN Profesör · Erciyes Üniversitesi 1
  25. TANER KORKMAZ Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi 1
  26. ÖZLEM ER Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi 1
  27. ÖZLEM SÖNMEZ Profesör · Acıbadem Mehmet Ali Aydınlar Üniversitesi 1
  28. ÖZLEM ÖZKUL Doçent · İstanbul Aydın Üniversitesi 1
  29. İRFAN ÇİÇİN Profesör · İstinye Üniversitesi 1
  30. İSMAİL BEYPINAR Doçent · Alanya Alaaddin Keykubat Üniversitesi 1

National collaboration 12 institutions

Within own university1 joint works · Marmara Üniversitesi

  1. İstanbul Üniversitesi 16 works · 20 academics
  2. İstinye Üniversitesi 2 works · 2 academics
  3. Acıbadem Mehmet Ali Aydınlar Üniversitesi 1 works · 5 academics
  4. Afyonkarahisar Sağlık Bilimleri Üniversitesi 1 works · 1 academics
  5. Alanya Alaaddin Keykubat Üniversitesi 1 works · 1 academics
  6. Erciyes Üniversitesi 1 works · 1 academics
  7. Necmettin Erbakan Üniversitesi 1 works · 1 academics
  8. Sağlık Bilimleri Üniversitesi 1 works · 1 academics
  9. Trakya Üniversitesi 1 works · 3 academics
  10. İstanbul Aydın Üniversitesi 1 works · 1 academics
Show all (12)
  1. İstanbul Medipol Üniversitesi 1 works · 1 academics
  2. İstanbul Yeni Yüzyıl Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 38

MUHAMMED ZÜBEYR ÜÇÜNCÜ 4ADNAN AYDINER 2ALİŞAN ZIRTILOĞLU 2FATİH TUFAN 2AKBAR AKBAROVARZU UZUNERATAKAN DEMİRAYSUN FATMA AKKUŞBANU ATALARCAN ÖZDEMİR TÜZERELİF KARAKOÇEMİNE NİLÜFER GÜLERESİN AKTAŞ ÇETİNHANDE ALİBAŞKADRİ ALTUNDAĞMEHMET ALİ KAPLANMELİHA NALÇACIMERAL GÜNALDIMUSTAFA TEOMAN YANMAZNAZIM SERDAL TURHALNECDET ÜSKENTNEZİHE SEDEN KÜÇÜCÜKNİL MOLİNAS MANDELOSMAN GÖKHAN DEMİRPEMRA CÖBEK ÜNALANPOLAT OLGUNSELMA SARISEMRA PAYDAŞSERKAN KESKİNSEVİL BAVBEKSEZAİ VATANSEVERSUNA BÜYÜKÖZTÜRKTARIK DEMİRYEŞİM ERALPÇİĞDEM USUL AFŞARÖZKAN ALANİREM KILIÇŞEYDA GÜNDÜZ

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.